Tissue Repair Ltd (ASX:TRP)
0.1550
0.00 (0.00%)
Mar 3, 2026, 3:43 PM AEST
Tissue Repair Revenue
Tissue Repair had revenue of 1.98M AUD in the half year ending June 30, 2025, with 103.67% growth. This brings the company's revenue in the last twelve months to 3.26M, up 23.90% year-over-year. In the fiscal year ending June 30, 2025, Tissue Repair had annual revenue of 2.63M with 47.04% growth.
Revenue (ttm)
3.26M
Revenue Growth
+23.90%
P/S Ratio
2.87
Revenue / Employee
n/a
Employees
n/a
Market Cap
9.37M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 2.63M | 842.43K | 47.04% |
| Jun 30, 2024 | 1.79M | 819.21K | 84.31% |
| Jun 30, 2023 | 971.66K | 799.73K | 465.18% |
| Jun 30, 2022 | 171.92K | 19.29K | 12.63% |
| Jun 30, 2021 | 152.64K | 152.48K | 97,743.59% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chimeric Therapeutics | 9.75M |
| Immuron | 7.48M |
| Neurotech International | 7.07M |
| Noxopharm | 2.68M |
| Nexalis Therapeutics | 767.69K |
| AdAlta | 608.07K |
| Bio-Gene Technology | 390.63K |
| Invex Therapeutics | 229.08K |